General Information of Drug (ID: DM4ME02)

Drug Name
Ticarcillin Drug Info
Synonyms
TIPC; Ticarcilina; Ticarcilline; Ticarcillinum; Ticarcillin Supplement; Ticillin [veterinary]; BRL-2288; Ticarcilina[INN-Spanish]; Ticarcillin (INN); Ticarcillin [INN:BAN]; Ticarcilline [INN-French]; Ticarcillinum [INN-Latin]; Ticillin [veterinary] (TN); Timentin (TN); A-carboxy-3-thienylmethylpenicillin; Alpha-carboxy-3-thienylmethylpenicillin; (2S,5R,6R)-6-[[(2R)-3-hydroxy-3-oxo-2-thiophen-3-ylpropanoyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-{[(2R)-2-carboxy-2-(3-thienyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-{[(2R)-2-carboxy-2-thiophen-3-ylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 6beta-{[(2R)-2-carboxy-2-thiophen-3-ylacetyl]amino}-2,2-dimethylpenam-3alpha-carboxylic acid
Therapeutic ClassAntibiotics
Cross-matching ID
PubChem CID
36921
ChEBI ID
CHEMBL9587
CAS Number
CAS 34787-01-4
TTD Drug ID
D08USU
INTEDE Drug ID
DR2409

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Mineral absorption 2.31 0.00e+0 48/60 (80%) MT1E;MT1F;MT1HL1;...
Salivary secretion 1.88 1.00e-2 76/93 (81.72%) DMBT1;PRKACB;CST3;...
ECM-receptor interaction 1.84 1.33e-2 80/88 (90.91%) TNC;ITGA6;COL1A1;...
Homologous recombination 1.79 2.75e-2 35/41 (85.37%) RAD51C;BARD1;TOPBP1;...
Glycosaminoglycan degradation 1.72 4.80e-2 19/19 (100%) GUSB;HYAL1;HEXB;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 10uM 6H, 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 10uM 6H, 24H